HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology

Absolute Quantitation of DNA Methylation of 28 Candidate Genes in Prostate Cancer Using Pyrosequencing

(2013) Nataڑa Vasiljeviš et al.   DISEASE MARKERS

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 g

(2012) Véronique Quillien et al.   CANCER

Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia

(2012) Lisa Mirabello et al.   INTERNATIONAL JOURNAL OF CANCER

Methylation of Human Papillomavirus Type 16 Genome and Risk of Cervical Precancer in a Costa Rican Population

(2012) Lisa Mirabello et al.   JNCI-Journal of the National Cancer Institute

Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3

(2012) Nicolas Wentzensen et al.   JNCI-Journal of the National Cancer Institute

New Technologies and Procedures for Cervical Cancer Screening

(2012) Jack Cuzick et al.   VACCINE

Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial

(2011) A Castañon et al.   BRITISH JOURNAL OF CANCER

Combined Promoter Methylation Analysis of CADM1 and MAL: An Objective Triage Tool for High-Risk Human Papillomavirus DNA-Positive Women

(2011) A. T. Hesselink et al.   CLINICAL CANCER RESEARCH

Methylation-sensitive high-resolution melting in the context of legislative requirements for validation of analytical procedures for diagnostic applications

(2011) Tomasz K Wojdacz   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Eurogin 2010 roadmap on cervical cancer prevention

(2011) Silvia Franceschi et al.   INTERNATIONAL JOURNAL OF CANCER

Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial

(2011) Eduardo Lazcano-Ponce et al.   LANCET

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women

(2010) Renée M. Overmeer et al.   INTERNATIONAL JOURNAL OF CANCER

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer

(2010) Saskia M Wilting et al.   Molecular Cancer

Host Factors in HPV-related Carcinogenesis: Cellular Mechanisms Controlling HPV Infections

(2009) Magnus von Knebel Doeberitz et al.   ARCHIVES OF MEDICAL RESEARCH

Continuous base identification for single-molecule nanopore DNA sequencing

(2009) James Clarke et al.   Nature Nanotechnology

Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy

(2009) Janet L. Brandsma et al.   VIROLOGY